Welcome to our dedicated page for Cameco SEC filings (Ticker: CCJ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Cameco Corporation (CCJ) SEC filings, where the company furnishes its U.S. regulatory disclosures as a foreign private issuer. Cameco files an annual report on Form 40-F, which includes its audited annual financial statements prepared in accordance with IFRS, management’s discussion and analysis (MD&A), and its Canadian annual information form. These documents outline segment performance for Uranium, Fuel Services and Westinghouse, along with risk factors and other corporate information.
Between annual reports, Cameco submits Form 6-K current reports to furnish press releases, quarterly MD&A, condensed consolidated interim unaudited financial statements and officer certifications under the Sarbanes-Oxley Act. Recent 6-K filings listed in the input include exhibits such as quarterly financial statements, MD&A for periods ended June 30 and September 30, 2025, press releases on operational updates, long-term contracts and strategic partnerships, and certifications from the chief executive officer and chief financial officer.
For investors analyzing Cameco’s uranium and nuclear fuel business, the 40-F and 6-K filings are primary sources for details on segment results, production volumes, long-term contracting, non-IFRS measures like adjusted net earnings and adjusted EBITDA, and disclosures about joint ventures such as JV Inkai. The filings also document Cameco’s equity-accounted investment in Westinghouse Electric Company, including its share of Westinghouse’s adjusted EBITDA and net earnings or losses, and information about projects in which Westinghouse participates.
On Stock Titan, these filings are paired with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly identify changes in production outlook, contract commitments, or segment performance without reading every page. Users can review annual Form 40-F reports, interim 6-Ks, and related exhibits, and then rely on AI-generated overviews to understand how Cameco describes its financial condition, operational plans and exposure across the nuclear fuel cycle.
Cameco Corporation filed a Form 6-K furnishing its 2025 Modern Slavery Report, covering the year ended December 31, 2025 for Cameco and Cameco Fuel Manufacturing Inc. The report explains how the company seeks to prevent forced and child labour in its operations and supply chains.
Cameco outlines policies such as its Code of Conduct and Ethics, People Policy, Supplier Code of Conduct and Ethics, and Procurement of Goods and Services Policy. It describes risk management processes, supplier screening, training, and reporting channels, and states it has not identified instances of forced or child labour.
Cameco Corporation is inviting shareholders to its 2026 annual meeting on May 7, 2026, at 10:00 a.m. CST via live webcast from Saskatoon. Holders of common shares at March 9, 2026 can vote on electing nine directors, reappointing KPMG as auditor, and an advisory say-on-pay resolution on executive compensation, as well as receive the 2025 audited financial statements. There were 435,532,978 common shares outstanding as of March 9, 2026. The circular explains Canadian residency-based ownership and voting limits, majority voting for directors, enhanced board independence, and updated director fee levels and share ownership requirements. Cameco uses notice-and-access to distribute materials electronically and strongly encourages advance proxy voting.
Solium Financial Inc. filed a Form 144 notifying a proposed sale of 2,000 common shares with an aggregate amount shown as $216,080.00 and CUSIP 435532978, dated 03/24/2026. The filing lists prior acquisitions from LTI vesting of 987 shares on 03/03/2023 and 1,013 shares on 03/01/2024, and a disclosed sale of 4,000 shares by Ronald Liam Mooney on 01/05/2026 for $400,680.00.
Cameco Corporation filed an Annual Report on Form 40-F that includes its audited 2025 financial statements and related disclosures. The filing states 435,457,978 Common Shares outstanding as of December 31, 2025. Management and the CEO/CFO concluded that disclosure controls and internal control over financial reporting were effective as of December 31, 2025, and the auditor KPMG LLP attested to the effectiveness in its report accompanying the 2025 consolidated audited financial statements.
The filing discloses that Cameco implemented SAP S/4 HANA in April 2024 and modified/implemented related controls; it describes off-balance-sheet arrangements (financial assurances and long-term product purchase contracts) and identifies exhibits including the 2025 Annual Information Form, MD&A, audited statements, and governance materials.
Cameco Corporation has signed a major long-term uranium supply agreement with India’s Department of Atomic Energy. The contract covers nearly 22 million pounds of uranium ore concentrate (U3O8) over nine years, with an estimated total value of about $2.6 billion based on current uranium prices and exchange rates.
Deliveries are expected to run from 2027 through 2035, supporting fuel needs for India’s existing 24 nuclear reactors and its plan to expand capacity toward 100 GW by 2047. Cameco notes that these volumes were already included in its previously disclosed long-term contracting totals and five-year uranium price sensitivity analysis.
Cameco Corporation reported much stronger results for 2025, driven by all three segments: uranium, fuel services, and its 49% stake in Westinghouse. Revenue rose to $3.48 billion from $3.14 billion, while gross profit increased to $970 million from $783 million.
Net earnings attributable to equity holders jumped to $590 million from $172 million, and adjusted net earnings climbed to $627 million from $292 million. Adjusted EBITDA grew to $1.93 billion from $1.53 billion, supported by higher realized uranium and fuel services prices and stronger Westinghouse performance.
Cash provided by operations increased significantly to $1.41 billion from $905 million, leaving Cameco with $1.11 billion in cash and cash equivalents and $99.6 million in short-term investments at year-end. The company emphasizes a disciplined supply strategy, about 230 million pounds of uranium under long‑term contracts, and continued value-accretive contributions from Westinghouse, including a US$171.5 million cash distribution in 2025.
Cameco Corporation filed a Form 6-K to furnish its updated Code of Conduct and Ethics, which applies to all employees, senior executives and board directors worldwide. The Code emphasizes integrity, legal compliance and safety, covering insider trading, anti-corruption, competition law, imports/exports of nuclear materials, conflicts of interest, confidentiality, data privacy and protection of intellectual property.
It sets expectations for respectful, inclusive workplaces, human rights, environmental protection, community engagement and fair dealing with customers, suppliers and competitors. The document describes internal controls for accurate financial reporting and continuous disclosure, outlines how to report concerns (including an independent 24/7 Ethics Hotline), and confirms strong non‑retaliation protections. Governance of the Code rests with senior officers and board committees, with annual certifications and defined processes for investigating violations and approving any waivers.
Cameco Corporation has a notice to sell 25,000 common shares. The planned sale is listed through broker Solium Financial Inc. on the NYSE, with an approximate sale date of 01/07/2026 and an aggregate market value of 2,598,500.00. These 25,000 shares were acquired on the same date via a stock option exercise paid in cash.
During the past three months, Timothy S. Gitzel sold 50,000 common shares on 01/02/2026 for gross proceeds of 4,928,000.00 and another 50,000 shares on 12/19/2025 for 4,499,500.00. Shares outstanding were 435,457,978; this is a baseline figure, not the amount being sold.
A shareholder filed a Rule 144 notice to sell 1,000 common shares of the issuer through broker Solium Financial Inc. on or about 01/05/2026 on the NYSE. The filing lists an aggregate market value of 100170.00 for these shares and notes that 435457978 shares were outstanding. The shares to be sold were acquired on 03/03/2023 as a vesting of a long-term incentive (LTI) award, with payment made in cash on the same date.
By signing the notice, the selling shareholder represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and is reminded that intentional misstatements or omissions can constitute federal criminal violations.